Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism SIRT3 inhibitors(NAD-dependent protein deacetylase sirtuin-3, mitochondrial inhibitors), Epigenetic drug |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Myeloid Leukemia | Preclinical | China | 05 Oct 2024 |





